News Archive

Click on a press release headline below to view the full document.

Date	Press Release
09/08/2009	TransIT®-2020 Broad Spectrum, Animal-free Transfection Reagent from Mirus Bio goes head-to-head with FuGENE® HD and Lipofectamine™ 2000
05/28/2009	Ingenio™ Electroporation Solution provides an economical alternative to the amaxa Nucleofector® System and outperforms available electroporation solutions
07/22/2008	Research Products division continues independent operation as Mirus Bio LLC (pdf)
07/22/2008	Roche acquires Mirus to advance research in the field of RNAi delivery
04/24/2007	Mirus Bio Corporation Awarded $900,000 Federal Grant to Perfect microRNA Analysis